INS and Hypoglycemia: In Canada, the annual cost of insulin- and sulfonylurea-induced hypoglycemia in older type 2 diabetic adults attaining very tight glycemic control was estimated to be CAN$29,913,883 and CAN$35,583,966, respectively, for a combined cost of CAN$65,497,849.